| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07007637 A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous… |
Trial sites expanded: 160 -> 166 locations |
| 2026-05-16 | NCT07223138 A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous… |
Trial sites expanded: 10 -> 14 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06641089 | Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα… | Arthritis, Psoriatic | Recruiting |
| NCT06768671 | An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT06641076 | Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic… | Arthritis, Psoriatic | Active, Not Recruiting |
| NCT07007637 | A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous… | Hidradenitis Suppurativa | Enrolling by Invitation |
| NCT07223138 | A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous… | Arthritis, Psoriatic | Enrolling by Invitation |